Emerging Asian Pharma Markets Poised to Show Solid Growth in 2015
Sunday, February 1, 2015
The emerging pharmaceutical markets of Asia are expected, with a few exceptions, to grow this year and beyond, most providing attractive platforms for investments in the local industries, according to a series of analyses.
Separate reports on 5 Southeast Asia nations and 6 in the Middle East and central Asia predominantly are positive despite geopolitics threatening to upset the markets in some of the countries, according to Fast Market Research analysts.
Thailand has one of the best outlooks because it has positioned itself as an entry point to the more remote countries of Southeast Asia. Japan-based drugmakers such as Eisai already are establishing footholds in the country, which is ranked No. 12 of 19 key Asia Pacific markets.